ScoreWhy is Xvivo Perfusion AB ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 35.19%
2
With a growth in Net Profit of 935.09%, the company declared Outstanding results in Jun 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at SEK 236.35 MM
- PRE-TAX PROFIT(Q) At SEK 32.73 MM has Grown at 996.52%
- NET PROFIT(Q) At SEK 16.28 MM has Grown at 1,186.1%
3
With ROE of 3.39%, it has a very expensive valuation with a 4.12 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 39.50%, its profits have fallen by -54.2%
4
Market Beating Performance
- The stock has generated a return of 39.50% in the last 1 year, much higher than market (OMX Stockholm 30) returns of 27.70%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Xvivo Perfusion AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Xvivo Perfusion AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Xvivo Perfusion AB
39.5%
30.70
48.48%
OMX Stockholm 30
27.7%
1.79
15.50%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.19%
EBIT Growth (5y)
47.44%
EBIT to Interest (avg)
14.29
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.37
Tax Ratio
32.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.10%
ROE (avg)
3.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
122
Industry P/E
Price to Book Value
4.12
EV to EBIT
94.18
EV to EBITDA
52.79
EV to Capital Employed
4.42
EV to Sales
10.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.69%
ROE (Latest)
3.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK 236.35 MM
PRE-TAX PROFIT(Q)
At SEK 32.73 MM has Grown at 996.52%
NET PROFIT(Q)
At SEK 16.28 MM has Grown at 1,186.1%
-9What is not working for the Company
ROCE(HY)
Lowest at 0%
OPERATING PROFIT(Q)
Lowest at SEK 19.96 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 8.35 %
NET PROFIT(Q)
Lowest at SEK 0 MM
EPS(Q)
Lowest at SEK 0
Here's what is working for Xvivo Perfusion AB
Pre-Tax Profit
At SEK 32.73 MM has Grown at 996.52%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK 16.28 MM has Grown at 1,186.1%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (SEK MM)
Operating Cash Flow
Highest at SEK 236.35 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Depreciation
Highest at SEK 19.96 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (SEK MM)
Here's what is not working for Xvivo Perfusion AB
Net Profit
At SEK 0 MM has Fallen at -100%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Operating Profit
Lowest at SEK 19.96 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (SEK MM)
Operating Profit Margin
Lowest at 8.35 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Profit
Lowest at SEK 0 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (SEK MM)
EPS
Lowest at SEK 0
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (SEK)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
